This inventor holds 1 USPTO granted patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovative Approach to Medicinal-Leech Extracts: The Contributions of Juergen Michels
Introduction
Juergen Michels, an inventive mind based in Köln, Germany, has made notable contributions to the field of biology and medicine. With a focus on enhancing the safety and efficacy of medicinal leech extracts, his work stands out in the realm of innovation.
Latest Patents
Michels holds a patent for a groundbreaking method aimed at inactivating undesired contaminations in leech extracts. The patent, entitled "Method for deactivating undesired contaminations in leech extracts," introduces a novel approach that utilizes electromagnetic radiation to inactivate viruses and bacteria present in these extracts. This innovation not only addresses safety concerns but also enhances the usability of leech extracts in medicinal applications.
Career Highlights
Juergen Michels is currently associated with Bayer Pharma Aktiengesellschaft, a leading global company in the pharmaceutical industry known for its commitment to research and development. His tenure at Bayer has allowed him to be part of pioneering research and has spotlighted his commitment to advancing medical science through innovative solutions.
Collaborations
Michels has had the opportunity to collaborate with talented colleagues such as Sebastian Schmidt and Jörg Peters. Together, they have continuously pushed the boundaries of what is possible in their field, demonstrating the importance of teamwork in driving significant advancements.
Conclusion
Juergen Michels's work exemplifies the impact that innovative thinking can have on traditional practices in medicine. His patent for deactivating contaminations in leech extracts not only represents a significant breakthrough but also exemplifies the importance of collaboration in fostering advancements in healthcare. As his career progresses at Bayer Pharma Aktiengesellschaft, the future looks bright for further innovations from this dedicated inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
